CVRx(US:CVRX) ZACKS·2025-11-06 01:11分组1 - CVRx reported a quarterly loss of $0.49 per share, slightly better than the Zacks Consensus Estimate of a loss of $0.50, and an improvement from a loss of $0.57 per share a year ago, indicating an earnings surprise of +2.00% [1] - The company generated revenues of $14.69 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 3.33%, and showing an increase from $13.37 million in the same quarter last year [2] - CVRx has surpassed consensus revenue estimates four times over the last four quarters, indicating a positive trend in revenue performance [2] 分组2 - The stock has underperformed, losing about 21.2% since the beginning of the year, while the S&P 500 has gained 15.1%, raising questions about the stock's future performance [3] - The current consensus EPS estimate for the upcoming quarter is -$0.41 on revenues of $15.99 million, and for the current fiscal year, it is -$2.00 on revenues of $56.13 million [7] - The Zacks Industry Rank for Medical - Instruments is in the top 37% of over 250 Zacks industries, suggesting that the industry outlook is favorable and could positively impact stock performance [8]